Exenatide Activates the APPL1-AMPK-PPARα Axis to Prevent Diabetic Cardiomyocyte Apoptosis

Figure 8

Protein expression levels of APPL1, p-AMPK/T-AMPK, PPARα, GRP78, and NF-κB in each group.